EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Primary Radiation Therapy for Patients With Widespread or Unresectable Keloids

Tsai-Ling Tsai, Yu-Chi Huang, Yi-Han Chang, Chao-Kai Hsu, Yuan-Yu Hsueh, Kuo-Shu Hung, Wei-Ting Hsueh

Practical Radiation Oncology · 2026

DOI: 10.1016/j.prro.2026.02.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical Radiation Oncology, 2026. Verfasst von Tsai-Ling Tsai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Keloid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Cheng Kung University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Keloids are scars that grow beyond their original margins, typically presenting as pigmented, thickened lesions accompanied by pain and pruritus that affects patients' quality of life. Keloids can be resectable or unresectable, and currently, no gold standard treatment exists for widespread or unresectable keloids. Radiation therapy is effective for keloids, but the efficacy and safety of primary radiation therapy for unresectable keloids have rarely been reported. Our study aims to evaluate the clinical outcomes of primary radiation therapy as a definitive treatment for widespread or unresectable keloids. The primary endpoint is radiation therapy response, including symptomatic and cosmetic improvement. The secondary endpoint is the recurrence rate after radiation therapy. METHODS AND MATERIALS: We retrospectively reviewed 35 patients with 64 keloid lesions treated with primary radiation therapy between January 2010 and July 2023. All received 30 Gy in 6 fractions. Treatment modalities, including 6 MeV or 9 MeV electrons and photon-based intensity modulated radiation therapy, were individualized according to lesion thickness and anatomic complexity. Clinical improvements were evaluated using the Visual Analog Scale, Vancouver Scar Scale, and Japan Scar Workshop Scar Scale. Longitudinal outcomes were analyzed using generalized estimating equations. RESULTS: Prominent symptomatic relief and cosmetic improvement were achieved with primary radiation therapy, with significant and sustained reductions in the Visual Analog Scale, Vancouver Scar Scale, and Japan Scar Workshop scores during follow-up. Disease control was excellent, with no cases of recurrence or serious adverse events. CONCLUSION: Primary radiation therapy is safe and effective for unresectable or extensive keloids. Both electron and photon beams provided reliable symptomatic relief, local control, and favorable cosmetic outcomes. Modern radiation therapy techniques, such as intensity modulated radiation therapy, provide similar efficacy with greater adaptability and may offer an innovative therapeutic option for challenging keloid cases. These findings highlight the expanding role of radiation therapy for benign but symptomatic dermatologic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeloidHumansFemaleMaleRetrospective StudiesTreatment OutcomeAdultMiddle AgedAdolescentAgedYoung Adult

Autor:innen und Institutionen

  • Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; International Research Center for Wound Repair and Regeneration, National Cheng Ku…
  • Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Surgery, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Division of Plastic and Reconstructive Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address: seine@ncku.edu.tw.

Förderung

  • National Cheng Kung University Hospital

Zitieren

APA

Tsai, T. L., Huang, Y. C., Chang, Y. H., Hsu, C. K., Hsueh, Y. Y., Hung, K. S., & Hsueh, W. T. (2026). Outcomes of Primary Radiation Therapy for Patients With Widespread or Unresectable Keloids. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2026.02.007

Vancouver

Tsai TL, Huang YC, Chang YH, Hsu CK, Hsueh YY, Hung KS, et al. Outcomes of Primary Radiation Therapy for Patients With Widespread or Unresectable Keloids. Practical Radiation Oncology. 2026. doi:10.1016/j.prro.2026.02.007

BibTeX
@article{Tsai2026,
  author = {Tsai, Tsai-Ling and Huang, Yu-Chi and Chang, Yi-Han and Hsu, Chao-Kai and Hsueh, Yuan-Yu and Hung, Kuo-Shu and Hsueh, Wei-Ting},
  title = {Outcomes of Primary Radiation Therapy for Patients With Widespread or Unresectable Keloids},
  journal = {Practical Radiation Oncology},
  year = {2026},
  doi = {10.1016/j.prro.2026.02.007}
}
Kostenlos starten →